UBS Sees Growing Risks to Cochlear’s Fiscal 2028 Earnings Recovery
UBS analysts say Advanced Bionics’ new implant platform is another incremental headwind for Cochlear, putting consensus forecasts for a fiscal 2028 earnings recovery at risk.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.